QSAR, docking, and CoMFA studies of GSK3 inhibitors.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current pharmaceutical design

• Publication date

  2010-07-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/138161210792389225PMID 20642432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unified QSAR & network‐based computational chemistry approach to antimicrobials. II. Multiple distance and triadic census analysis of antiparasitic drugs complex networks

  2010cited by this paper
• Trypano-PPI: a web server for prediction of unique targets in trypanosome proteome by using electrostatic parameters of protein-protein interactions.

  2010cited by this paper
• Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers.

  2010cited by this paper
• Synthesis of new dipyrrolo- and furopyrrolopyrazinones related to tripentones and their biological evaluation as potential kinases (CDKs1-5, GSK-3) inhibitors.

  2009cited by this paper
• Rho iso-alpha acids from hops inhibit the GSK-3/NF-κB pathway and reduce inflammatory markers associated with bone and cartilage degradation

  2009cited by this paper
• Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.

  2009cited by this paper
• Feature Selection and Linear/Nonlinear Regression Methods for the Accurate Prediction of Glycogen Synthase Kinase-3β Inhibitory Activities

  2009cited by this paper
• Prediction of enzyme classes from 3D structure: a general model and examples of experimental-theoretic scoring of peptide mass fingerprints of Leishmania proteins.

  2009cited by this paper
• Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species.

  2009cited by this paper
• Alignment-free prediction of polygalacturonases with pseudofolding topological indices: experimental isolation from Coffea arabica and prediction of a new sequence.

  2009cited by this paper
• Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.

  2009cited by this paper
• Proteomics, networks and connectivity indices

  2008cited by this paper
• Selectivity criterion for pyrazolo[3,4-b]pyrid[az]ine derivatives as GSK-3 inhibitors: CoMFA and molecular docking studies.

  2008cited by this paper
• The GSK3 hypothesis of Alzheimer's disease

  2008cited by this paper
• Pharmacological inhibition of GSK‐3 is not strictly correlated with a decrease in tyrosine phosphorylation of residues 216/279

  2008cited by this paper
• Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach.

  2008cited by this paper
• Predicting Kinase Selectivity Profiles Using Free-Wilson QSAR Analysis

  2008cited by this paper
• Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.

  2008cited by this paper
• Glycogen Synthase Kinase 3 Is a Potential Drug Target for African Trypanosomiasis Therapy

  2008cited by this paper
• Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents.

  2008cited by this paper
• 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.

  2007cited by this paper
• Unified QSAR approach to antimicrobials. Part 2: predicting activity against more than 90 different species in order to halt antibacterial resistance.

  2007cited by this paper
• Drug–target residence time and its implications for lead optimization

  2007cited by this paper
• Prediction of Tyrosinase Inhibition Activity Using Atom‐Based Bilinear Indices

  2007cited by this paper
• 3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: an insight into the criteria for selectivity.

  2007cited by this paper
• Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors.

  2007cited by this paper
• Computational chemistry comparison of stable/nonstable protein mutants classification models based on 3D and topological indices

  2007cited by this paper
• Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.

  2007cited by this paper
• Computational chemistry approach to protein kinase recognition using 3D stochastic van der Waals spectral moments

  2007cited by this paper
• Medicinal chemistry and bioinformatics--current trends in drugs discovery with networks topological indices.

  2007cited by this paper
• QSAR modeling of the inhibition of glycogen synthase kinase-3.

  2006cited by this paper
• Inhibitory mode of N-phenyl-4-pyrazolo[1,5-b] pyridazin-3-ylpyrimidin-2-amine series derivatives against GSK-3: molecular docking and 3D-QSAR analyses.

  2006cited by this paper
• 3D QSAR for GSK-3beta inhibition by indirubin analogues.

  2006cited by this paper
• Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.

  2006cited by this paper
• Opportunities and Challenges in Antiparasitic Drug Discovery

  2005cited by this paper
• SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors.

  2005cited by this paper
• 3D-QSAR and Docking Studies of Selective GSK-3beta Inhibitors. Comparison with a Thieno[2, 3-b]pyrrolizinone Derivative, a New Potential Lead for GSK-3beta Ligands

  2005cited by this paper
• A linear discrimination analysis based virtual screening of trichomonacidal lead-like compounds: outcomes of in silico studies supported by experimental results.

  2005cited by this paper
• QSAR modeling of the MAO inhibitory activity of xanthones derivatives.

  2004cited by this paper
• New hypoglycaemic agents selected by molecular topology.

  2004cited by this paper
• Pharmacological inhibitors of glycogen synthase kinase 3.

  2004cited by this paper
• Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.

  2004cited by this paper
• Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors.

  2004cited by this paper
• N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy.

  2004cited by this paper
• New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method.

  2003cited by this paper
• Synthesis and in vitro characterization of 1-(4-aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic acid derivatives. A new class of selective GSK-3 inhibitors.

  2003cited by this paper
• Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease.

  2003cited by this paper
• Glycogen synthase kinase (GSK)-3beta levels and activity in a neurodevelopmental rat model of schizophrenia.

  2003cited by this paper
• Chemotherapy of human African trypanosomiasis: current and future prospects.

  2003cited by this paper
• Discrimination and selection of new potential antibacterial compounds using simple topological descriptors.

  2003cited by this paper
• In Silico Studies toward the Discovery of New Anti-HIV Nucleoside Compounds with the Use of TOPS-MODE and 2D/3D Connectivity Indices, 1. Pyrimidyl Derivatives

  2002cited by this paper
• Structure-based classification of antibacterial activity.

  2002cited by this paper
• Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.

  2001cited by this paper
• The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

  2001cited by this paper
• Recent advances on the role of topological indices in drug discovery research.

  2001cited by this paper
• Glycogen synthase kinase-3: properties, functions, and regulation.

  2001cited by this paper
• Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity

  2001cited by this paper
• A novel approach for the virtual screening and rational design of anticancer compounds.

  2000cited by this paper
• Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

  2000cited by this paper
• Cell-Extracellular Matrix Interactions Stimulate the AP-1 Transcription Factor in an Integrin-Linked Kinase- and Glycogen Synthase Kinase 3-Dependent Manner

  1999cited by this paper
• Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.

  1999cited by this paper
• Glycogen synthase kinase-3: functions in oncogenesis and development.

  1992cited by this paper
• Molecular cloning and expression of glycogen synthase kinase‐3/factor A.

  1990cited by this paper
• A novel tubulin-dependent protein kinase forming a paired helical filament epitope on tau.

  1988cited by this paper

• In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies

  2023cites this paper
• A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies.

  2023cites this paper
• Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review.

  2021cites this paper
• Computational methods and tools for sustainable and green approaches in drug discovery

  2020cites this paper
• Methodologies Related to Computational Models in View of Developing Anti-Alzheimer Drugs: An Overview.

  2019cites this paper
• AntiMalarial Mode of Action (AMMA) Database: Data Selection, Verification and Chemical Space Analysis

  2018cites this paper
• Biochemistry & Pharmacology: Open Access

  2017cites this paper
• In silico and In vivo Toxicological Evaluation of Cissampelos Sympodialis Secondary Metabolites in Rattus Norvegicus.

  2017cites this paper
• The advancement of multidimensional QSAR for novel drug discovery - where are we headed?

  2017cites this paper
• State of Art: Review of Theoretical Study of GSK-3β and a New Neural Networks QSAR Studies for the Design of New Inhibitors Using 2D-Descriptors

  2015cites this paper
• GSK-3 as potential target for therapeutic intervention in cancer

  2014cites this paper
• Review of current chemoinformatic tools for modeling important aspects of CYPs-mediated drug metabolism. Integrating metabolism data with other biological profiles to enhance drug discovery.

  2014cites this paper
• Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's disease.

  2013cites this paper
• Abelson tyrosine-protein kinase 1 as principal target for drug discovery against leukemias. Role of the current computer-aided drug design methodologies.

  2013cites this paper
• Regulatory issues in management of chemicals in OECD member countries.

  2013cites this paper
• General theory for multiple input-output perturbations in complex molecular systems. 1. Linear QSPR electronegativity models in physical, organic, and medicinal chemistry.

  2013cites this paper
• MIANN models in medicinal, physical and organic chemistry.

  2013cites this paper
• Design of glycogen synthase kinase-3 inhibitors: an overview on recent advancements.

  2013cites this paper
• GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

  2012cites this paper
• Review of synthesis, biological assay, and QSAR studies of HMGR inhibitors.

  2012cites this paper
• QSAR and molecular docking techniques for the discovery of potent monoamine oxidase B inhibitors: computer-aided generation of new rasagiline bioisosteres.

  2012cites this paper
• Conotoxins: review and docking studies to determine potentials of conotoxin as an anticancer drug molecule.

  2012cites this paper
• Role of ligand-based drug design methodologies toward the discovery of new anti- Alzheimer agents: futures perspectives in Fragment-Based Ligand Design.

  2012cites this paper
• Boron containing compounds as protease inhibitors.

  2012cites this paper
• Wnt/beta-Catenin Signaling and Small Molecule Inhibitors

  2012cites this paper
• Computer-aided drug design methodologies toward the design of anti-hepatitis C agents.

  2012cites this paper
• Review of theoretical studies for prediction of neurodegenerative inhibitors.

  2012cites this paper
• Review of synthesis, assay, and prediction of β and γ-secretase inhibitors.

  2012cites this paper
• 3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.

  2012cites this paper
• Editorial: QSAR models for computer-aided drug design and molecular docking for disorders of the central nervous system and other diseases.

  2012cites this paper
• Recent advances on A₃ adenosine receptor antagonists by QSAR tools.

  2012cites this paper
• From QSAR models of drugs to complex networks: state-of-art review and introduction of new Markov-spectral moments indices.

  2012cites this paper
• Editorial: QSAR/QSPR models as enabling technologies for drug & targets discovery in: medicinal chemistry, microbiology-parasitology, neurosciences, bioinformatics, proteomics and other biomedical sciences.

  2012cites this paper
• Review of QSAR for DNA polymerase inhibitors and new models for heterogeneous series of compounds.

  2011cites this paper
• 3D-QSPR Method of Computational Technique Applied on Red Reactive Dyes by Using CoMFA Strategy

  2011cites this paper
• Current computational approaches towards the rational design of new insecticidal agents.

  2011cites this paper
• Construcción QSAR de redes complejas de compuestos de interés en Química Farmacéutica, Microbiología y Parasitología

  2011cites this paper
• MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.

  2011cites this paper
• From chemical graphs in computer-aided drug design to general Markov-Galvez indices of drug-target, proteome, drug-parasitic disease, technological, and social-legal networks.

  2011cites this paper
• Review of synthesis, biological assay and QSAR studies of β-secretase inhibitors.

  2011cites this paper
• Current drug design of anti-HIV agents through the inhibition of C-C chemokine receptor type 5.

  2011cites this paper
• Revision of QSAR, docking, and molecular modeling studies of anti-influenza virus A (H1N1) drugs and targets: analysis of hemagglutinins 3D structure.

  2011cites this paper
• QSAR and complex networks in pharmaceutical design, microbiology, parasitology, toxicology, cancer, and neurosciences.

  2010cites this paper